NCT02078856View on ClinicalTrials.gov

Double-blind, Randomised Study of A3384 in BAM/BAD

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Bile Acid Malabsorption
Interventions
DRUG

A3384

Trial Locations (3)

Unknown

Sahlgrenska Academy, Gothenburg

Kärnsjukhuset, Skövde

W12 0HS

Hammersmith Hospital, Imperial College Healthcare NHS Trust, London

Sponsors

Lead Sponsor

Albireo
All Listed Sponsors
lead

Albireo

INDUSTRY

NCT02078856 - Double-blind, Randomised Study of A3384 in BAM/BAD | Biotech Hunter | Biotech Hunter